• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks
    life science investing

    Zoetis IPO Could Spur More Health Care Stock Issuance

    Investing News Network
    Feb. 05, 2013 05:07PM PST
    Life Science Investing

    The Wall Street Journal reported that Zoetis Inc.’s successful IPO last week triggered banker movements and is likely to spur more health care deals this year.

    The Wall Street Journal reported that Zoetis Inc.’s successful IPO last week triggered banker movements and is likely to spur more health care deals this year.

    As quoted in the market news:

    Zoetis’s IPO was a milestone for two expanding investment banks, Jefferies Group Inc. and Guggenheim Partners LLC. For both firms it was the first time they were in lead roles (in banker parlance, “bookrunners”) on an IPO over $1 billion, according to Dealogic. They joined a group of the usual suspects on the deal in that role, including J.P. Morgan & Co., Bank of America Corp., and Morgan Stanley.

    Click here to read the full Wall Street Journal report.

    j.p. morganbank of americalife science investing
    The Conversation (0)

    Go Deeper

    AI Powered
     Thian Chew, CEO of Invion

    New Deal Could Spark Invion’s Entry into Pet Cancer Market, CEO Says

    Medical pills branded with Canadian flag.

    Canadian Pharma Stocks: 5 Biggest Companies

    Latest News

    Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

    Nextech3D.ai: Disrupting the Global Events Management Industry with AI and Blockchain

    Appendix 4C and Quarterly Activities Report - September 2025

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Life Science Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES